Skip to main content
Equibles

AFYA · Afya Ltd · Financials

Track AFYA — free

Use AFYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AFYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.20 -0.63 (-5.82%) Q4 2025 earnings call transcript
Rebalance outlook locked
Market Cap
$958.22M
Shares
88.48M
Volume · Oct 28 439.27K Avg daily vol (3M) 317.02K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
3.7B +11.9%
FY2025 Revenue FY2017–FY2025
Net Income
752.46M +19.2%
FY2025 Net Income FY2017–FY2025
Gross Margin
64.46% +1.2pp
FY2025 Gross Margin FY2017–FY2025
Operating Margin
32.81% +2.2pp
FY2025 Operating Margin FY2017–FY2025
Diluted EPS
8.24 +18.9%
FY2025 Diluted EPS FY2017–FY2025
Operating Cash Flow
1.53B +6.9%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
BRL 3.7B 3.3B 2.88B 2.33B 1.72B 1.2B 750.63M 333.94M 216.01M
BRL 1.31B 1.22B 1.11B 859.55M 652.3M 434.65M -308.85M 168.05M 124.07M
BRL 2.38B 2.09B 1.77B 1.47B 1.07B 766.54M 441.78M 165.88M 91.94M
BRL 114.8M 85.47M 74.14M 48.22M 39.51M 18.36M -12.97M 3.53M 2.15M
BRL 1.11B 1.01B 940.13M 798.15M 622.62M 402.86M 239.12M 70.03M 45.36M
BRL 373.34M 333.34M 289.51M 206.22M 154.22M -108.74M -73.15M 9.08M 4.02M
BRL 1.21B 1.01B 767.06M 664.1M 440.9M 363.34M 205.25M 96.45M 49.34M
BRL 561.02M 458.74M 457.62M 349.89M 243.8M 98.27M 72.37M 8.15M 3.59M
BRL 860.95M 676.39M 429.58M 428.43M 273.46M 335.05M 186.94M 98.72M 50.98M
BRL — 27.47M 24.17M 35.68M 31.18M 27.07M 14.18M 3.99M 2.5M
BRL 752.46M 631.51M 386.32M 373.57M 223.33M 292.08M 153.92M 86.35M 45.39M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2025: 89.37M in buybacks, 295.38M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Lease liabilities 2025-12-31 BRL 1,065,746,000 20-F filed 2026-03-31
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
BRL 55,772,000
Noncurrent lease liabilities
BRL 1,009,974,000
Noncurrent long-term borrowings 2025-12-31 BRL 1,993,599,000 20-F filed 2026-03-31
Short-term borrowings 2025-12-31 BRL 60,668,000 20-F filed 2026-03-31
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1771007 CUSIP G01125106 13F (30d) 2 filings 2 filers Visit website Investor relations